Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – Should You Sell?

Oxford BioMedica (OTCMKTS:OXBDF) gapped down before the market opened on Thursday. The stock had previously closed at $7.65, but opened at $6.70. Oxford BioMedica shares last traded at $6.70, with a volume of 7,462 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the company presently has an average rating of “Hold”.

Oxford BioMedica Stock Performance

The company has a 50-day simple moving average of $6.83 and a 200-day simple moving average of $7.61.

Oxford BioMedica Company Profile

Oxford BioMedica plc is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. The company works with biotechnology and pharmaceutical customers to develop, manufacture and test viral vectors and other biological materials used in advanced therapies.

Its capabilities include process and analytical development, clinical and commercial manufacturing, quality control, regulatory support and technology transfer. Oxford BioMedica has particular expertise in lentiviral vectors, which are used to deliver genetic material into cells, and also provides services involving adeno-associated virus and other viral-vector platforms.

Founded in 1995 and headquartered in Oxford, England, the company serves customers internationally across the pharmaceutical and biotechnology industries.